Recs

0

Innospec Shares Dropped: What You Need to Know

Watch stocks you care about

The single, easiest way to keep track of all the stocks that matter...

Your own personalized stock watchlist!

It's a 100% FREE Motley Fool service...

Click Here Now

Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis.

What: Specialty chemicals maker Innospec (Nasdaq: IOSP  ) is due to report Q2 earnings in just a few short hours. Investors aren't waiting around for the shoe to drop. They're selling out ahead of earnings, and the stock is down 9% as of this writing.

So what: Can you blame them? I mean, last week, Innospec rival Polypore (NYSE: PPO  ) reported absolutely fabulous earnings -- up 85% year over year. The stock sold off 10% anyway. Who wants to sit around for an encore of that performance?

Now what: Polypore's problem was that it planned to expand manufacturing capacity for its line of lithium-ion membranes, hurting Q3 earnings. There's no reason to believe Innospec will be adding capacity, though. More importantly, the stocks differ in another key respect: valuation. When Polypore sold off, it was selling for 40 times earnings, and looking to get even more expensive. Innospec, in contrast, costs only 6.6 times earnings today. While an earnings miss, or weak guidance, could certainly change the equation and make the stock look more expensive, the risk still looks much lower than what we saw at Polypore last week.

Will Innospec spook the market tonight? Add the stock to your Fool Watchlist and find out.

The Steve Jobs Betrayal
You may already know that in the final year of his life, Jobs revealed a stunning betrayal — and told his biographer, "I will spend my last dying breath... and every penny of Apple's $40 billion in the bank to right this wrong." What was it that made Jobs so irate — and why could it make a few in-the-know investors some major profits over the coming months and years?

Enter your email address below to find out what made Jobs so enraged!

Fool contributor Rich Smith does not own (or short) shares of either company named above. The Motley Fool has a disclosure policy.

Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.


Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Compare Brokers

Fool Disclosure

DocumentId: 1535517, ~/Articles/ArticleHandler.aspx, 5/26/2012 12:05:53 PM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

Today's Market

updated 14 hours ago Sponsored by:
DOW 12,454.83 -74.92 -0.60%
S&P 500 1,317.82 -2.86 -0.22%
NASD 2,837.53 -1.85 -0.07%

Create My Watchlist

Go to My Watchlist

You don't seem to be following any stocks yet!

Better investing starts with a watchlist. Now you can create a personalized watchlist and get immediate access to the personalized information you need to make successful investing decisions.

Data delayed up to 5 minutes

Related Tickers

5/25/2012 4:01 PM
PPO $36.87 Up +0.19 +0.52%
Polypore Internati… CAPS Rating: ***
IOSP $26.87 Down -0.01 -0.04%
Innospec, Inc. CAPS Rating: *****

Advertisement